Literature DB >> 14982724

STAT1 binds to the herpes simplex virus type 1 latency-associated transcript promoter.

John D Kriesel1, Brandt B Jones, Kimberly M Dahms, S L Spruance.   

Abstract

The authors hypothesized that environmental stimuli induce cytokines that act through an intracellular cascade, which includes signal transducers and activators of transcription (STATs), to change herpes simplex virus (HSV) gene expression, thereby inducing viral reactivation. The HSV type 1 (HSV-1) latency-associated transcript (LAT) gene regulates viral reactivation within neurons via an unknown mechanism. HSV-1 deletion mutants that are missing key portions of the LAT gene, particularly the 3' region of the LAT promoter, do not reactivate normally in vivo. The authors hypothesized that STAT transcription factors may bind in this region to regulate viral reactivation. Electrophoretic mobility shift assay (EMSA) experiments were performed by incubating mouse trigeminal ganglion (TG) nuclear extracts with each of three overlapping sequences representing the 3' region of the HSV-1 LAT promoter (referred to as oligos L1, L2, and L3). The ganglionic nuclear extracts bound specifically to oligos L1 and L3, but not L2. Oligos L1 and L3 contain predicted STAT binding sequences whereas L2 does not. Specific binding to oligo L3 (including the TATA box sequence) was supershifted by incubating with anti-STAT1 antibodies, but not by incubating with anti-STAT3 or anti-STAT5a antibodies. Specific L3 binding was reduced by competing with excess unlabeled STAT1 consensus sequences. These results indicate that STAT1, probably as part of a complex, is capable of binding to the LAT promoter on or near the TATA box. Further studies are required to determine if STAT1 is required for LAT expression in vivo. This work supports the hypothesis that interferons act through STAT1 to regulate the expression of HSV-1 LAT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982724     DOI: 10.1080/13550280490261680

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  36 in total

1.  Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.

Authors:  Maryam Ahmed; Martin Lock; Cathie G Miller; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 2.  The latency associated transcripts (LAT) of herpes simplex virus: still no end in sight.

Authors:  T M Block; J M Hill
Journal:  J Neurovirol       Date:  1997-10       Impact factor: 2.643

3.  A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome.

Authors:  S K Thomas; C E Lilley; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits.

Authors:  G C Perng; S M Slanina; A Yukht; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Mechanisms of herpes simplex virus type 1 reactivation.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Herpes simplex virus latent phase transcription facilitates in vivo reactivation.

Authors:  J M Hill; F Sedarati; R T Javier; E K Wagner; J G Stevens
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

7.  Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript.

Authors:  Gail Henderson; Weiping Peng; Ling Jin; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler; Clinton Jones
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

8.  Leukemia inhibitory factor and NGF regulate signal transducers and activators of transcription activation in sympathetic ganglia: convergence of cytokine- and neurotrophin-signaling pathways.

Authors:  P Rajan; T Gearan; J S Fink
Journal:  Brain Res       Date:  1998-08-17       Impact factor: 3.252

9.  The roles of the cAMP-response element and TATA box in expression of the herpes simplex virus type 1 latency-associated transcripts.

Authors:  C E Ackland-Berglund; D J Davido; D A Leib
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

10.  Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency.

Authors:  S K Thomas; G Gough; D S Latchman; R S Coffin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

View more
  6 in total

1.  The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation.

Authors:  J R Kent; N W Fraser
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

Review 2.  A common neuronal response to alphaherpesvirus infection.

Authors:  Moriah L Szpara; Oren Kobiler; Lynn W Enquist
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

Review 3.  Role of chromatin during herpesvirus infections.

Authors:  Sebla B Kutluay; Steven J Triezenberg
Journal:  Biochim Biophys Acta       Date:  2009-03-31

4.  Neuronal IFN signaling is dispensable for the establishment of HSV-1 latency.

Authors:  Pamela C Rosato; Sarah Katzenell; Jean M Pesola; Brian North; Donald M Coen; David A Leib
Journal:  Virology       Date:  2016-08-10       Impact factor: 3.616

Review 5.  How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses.

Authors:  Marina I Arleevskaya; Olga A Kravtsova; Julie Lemerle; Yves Renaudineau; Anatoly P Tsibulkin
Journal:  Front Microbiol       Date:  2016-08-17       Impact factor: 5.640

6.  Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS.

Authors:  Carola J Maturana; Jessica L Verpeut; Thomas J Pisano; Zahra M Dhanerawala; Andrew Esteves; Lynn W Enquist; Esteban A Engel
Journal:  Mol Ther Methods Clin Dev       Date:  2020-04-14       Impact factor: 6.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.